We inform you about the latest infectious disease outbreaks from overseas. Read the new articles.

Information as of October 29, 2025

National poliovirus sequencing capacity enhances Cameroon’s outbreak response |23 October 2025|African Region
Yaounde – For the first time ever, a circulating variant poliovirus type 3 (cVDPV3) was fully sequenced in Cameroon, marking a major milestone in Africa’s efforts to detect and respond faster to polio outbreaks. Poliovirus has three types: 1, 2, and 3. Although wild polio type 3 was declared eradicated in 2019, variant type 3 can still appear where immunity is low, making quick detection and response essential to contain outbreaks.

WHO hands over life-saving equipment to Uganda’s Ministry of Health under D-CARD Afr…|24 October 2025|African Region
At a small health center in rural Sembabule, a nurse recalls the heartbreak of turning away patients due to lack of basic diagnostic tools. “We could suspect hypertension or diabetes, but without the right equipment, we couldn’t confirm or act early,” she said. That reality is now changing.Today, the World Health Organization (WHO) handed over life-saving medical equipment to Uganda’s Ministry of Health under the Diabetes and Cardiovascular (D-CARD) Africa Project—marking a major step forward in the country’s fight against noncommunicable diseases (NCDs).

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade|2025-10-22| Global situation
Moreover, receipt of SARS-CoV-2 mRNA vaccines within 100 days of initiating ICI is associated with significantly improved median and three-year overall survival in multiple large retrospective cohorts. This benefit is similar among patients with immunologically cold tumours. Together, these results demonstrate that clinically available mRNA vaccines targeting non-tumour-related antigens are potent immune modulators capable of sensitizing tumours to ICIs.